- Report
- May 2026
- 66 Pages
Spain
From €4612EUR$4,995USD£3,896GBP
- Report
- May 2026
- 58 Pages
Italy
From €4612EUR$4,995USD£3,896GBP
- Report
- May 2026
- 61 Pages
France
From €4612EUR$4,995USD£3,896GBP
- Report
- May 2026
- 59 Pages
South Korea
From €4612EUR$4,995USD£3,896GBP
- Report
- May 2026
- 59 Pages
Japan
From €4612EUR$4,995USD£3,896GBP
- Report
- May 2026
- 59 Pages
China
From €4612EUR$4,995USD£3,896GBP
The Cardiac Marker market is a segment of the Pharmaceuticals industry that focuses on the development and production of drugs and other treatments for cardiovascular diseases. Cardiac markers are substances that are released into the bloodstream when the heart is damaged or stressed. These markers can be used to diagnose and monitor the progression of cardiovascular diseases, such as heart attack, stroke, and congestive heart failure. The market is driven by the increasing prevalence of cardiovascular diseases, the growing demand for early diagnosis and treatment, and the development of new technologies.
The Cardiac Marker market is highly competitive, with a number of large and small companies operating in the space. Some of the major players in the market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more